Related Experiment Videos
[Adjuvant chemotherapy in dysgerminoma]
A Fechtig1, R P de Dycker, T Schumacher
1Frauenklinik Marienhospital Altenessen, Akademisches Lehrkrankenhaus Universität (GHS) Essen.
Geburtshilfe Und Frauenheilkunde
|May 1, 1991
Summary
This case report details a young patient diagnosed with ovarian dysgerminoma. Postoperative chemotherapy was chosen over radiotherapy due to elevated tumor markers, leading to no signs of recurrence.
Area of Science:
- Gynecologic Oncology
- Reproductive Endocrinology
- Pediatric Oncology
Background:
- Dysgerminoma is a rare germ cell tumor of the ovary, often presenting in young patients.
- Ovarian germ cell tumors require careful management due to their potential for metastasis and recurrence.
Observation:
- A young patient presented with a right ovarian dysgerminoma.
- Initial surgical management involved right-side adnexectomy and hysterectomy.
- Elevated tumor marker levels suggested involvement of other germ cell elements.
Findings:
- Postoperative chemotherapy was administered instead of radiotherapy.
- Regular monitoring of tumor markers was conducted during follow-up.
- No evidence of tumor recurrence has been observed to date.
Implications:
- This case highlights the importance of considering chemotherapy for ovarian dysgerminoma when tumor markers indicate broader germ cell involvement.
- Adjuvant chemotherapy may be a viable alternative to radiotherapy in select cases, potentially reducing long-term side effects.
- Close tumor marker surveillance is crucial for early detection of recurrence in ovarian germ cell tumors.